InvestorsHub Logo
Followers 209
Posts 32159
Boards Moderated 1
Alias Born 06/30/2009

Re: Lemoncat post# 393344

Friday, 09/16/2022 11:21:27 PM

Friday, September 16, 2022 11:21:27 PM

Post# of 403037
"I would hope they have some baseline data in order to alter dosing strategies to improve effectiveness."

I understand what you're saying and I think it lines up nicely with the writers intent.
But I believe that rather than developing the baseline effectiveness data with noses, the data exists from the B-CV trial and that "Ongoing efforts are focused on dosing strategies" doesn't indicate that there are ongoing trials being conducted.....just that the issue of dosing is being considered.

Saying the words "ongoing in vivo testing" just isn't all that difficult. IF that's what is happening.

“I have had a wonderful time but this wasn't it.”
..........Groucho

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News